-
Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib’s Potential as a Precision Medicine for Cancer
01 Apr 2024 13:15 GMT
… 01, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: … , ovarian and others. About Cyclacel Pharmaceuticals, Inc. Cyclacel is a clinical … or otherwise. Contacts © Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. …
-
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
25 Apr 2024 18:27 GMT
… dipped 26% to $0.39.
Cyclacel Pharmaceuticals, Inc. CYCC fell 24% to …
-
CYCC Stock Earnings: Cyclacel Pharmaceuticals Misses EPS for Q4 2023
20 Mar 2024 01:44 GMT
Source: iQoncept / Shutterstock
Cyclacel Pharmaceuticals (NASDAQ:CYCC) just reported results … the fourth quarter of 2023.
Cyclacel Pharmaceuticals reported earnings per share of … ;03/cycc-stock-earnings-cyclacel-pharmaceuticals-for-q4-of-2023…
-
Cyclacel Pharmaceuticals, Inc. (CYCC) Q4 2023 Earnings Call Transcript
20 Mar 2024 00:04 GMT
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q4 2023 … afternoon and welcome to the Cyclacel Pharmaceuticals Fourth Quarter and Full Year …
-
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
19 Mar 2024 20:05 GMT
… or otherwise. Contacts
© Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The … Cyclacel® are trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE: Cyclacel Pharmaceuticals, Inc.
CYCLACEL PHARMACEUTICALS, INC.
CONSOLIDATED STATEMENTS …
-
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results
13 Mar 2024 20:05 GMT
… 13, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: … replay for 7 days. About Cyclacel Pharmaceuticals, Inc. Cyclacel is a … or otherwise. Contacts © Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The …
-
£2.3M R&D Tax Credit from the UK Governnent- Cyclacel Pharmaceuticals Medicine Advancements!
07 Mar 2024 15:49 GMT
… Tax Credit from UK Government
Cyclacel Pharmaceuticals Reaps Financial Reward
According … to Seeking Alpha, Cyclacel Pharmaceuticals listed on NASDAQ as CYCC … from the UK Governnent- Cyclacel Pharmaceuticals Medicine Advancements! (PHOTO: Metabolon …
-
Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
07 Mar 2024 14:15 GMT
… 07, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: … for MTAP deleted cancers. About Cyclacel Pharmaceuticals, Inc. Cyclacel is a … or otherwise. Contacts © Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The …
-
Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit
06 Mar 2024 14:15 GMT
… 06, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: … ; Chief Operating Officer. About Cyclacel Pharmaceuticals, Inc.
Cyclacel is a clinical … .com. Contacts © Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. …
-
Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conference
20 Feb 2024 14:15 GMT
… . 20, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: … of this press release. About Cyclacel Pharmaceuticals, Inc.
Cyclacel is a … or otherwise. Contacts © Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The …